Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Jeannot, Katy ^a,c   Diancourt, Laure ^a   Vaux, Sophie ^b   Thouverez, Michelle ^c   Ribeiro, Amandina ^a   Coignard, Bruno ^b   Courvalin, Patrice ^a   Brisse, Sylvain ^a,d  

^a INSTITUT PASTEUR   (France)

^b French Institute for Public Health Surveillance InVS   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BLAOXA23 GENE; BLAOXA24 GENE; BLAOXA58 GENE; CLONAL VARIATION; CONTROLLED STUDY; EPIDEMIC; FRANCE; GENE IDENTIFICATION; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTIONS; CLASSIFICATION; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FRANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION;

EID: 84919341208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115452     Document Type: Article

References (39)

1. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
2. Gogou V, Pournaras S, Giannouli M, Voulgari E, Piperaki ET, et al. (2011) Evolution of multidrugresistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). J Antimicrob Chemother 66: 2767-2772.
3. Poirel L, Bonnin RA, Nordmann P (2011) Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 63: 1061-1067.
4. Poirel L, Naas T, Nordmann P (2010) Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother 54: 24-38.
5. Higgins PG, Perez-Llarena FJ, Zander E, Fernandez A, Bou G, et al. (2013) OXA-235, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 57: 2121-2126.
6. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S (2010) The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5: e10034.
7. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, et al. (2005) Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43: 4328-4335.
8. Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, et al. (1996) Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 34: 1519-1525.
9. van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, et al. (2004) Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 155: 105-112.
10. Higgins PG, Dammhayn C, Hackel M, Seifert H (2009) Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother.
11. Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, et al. (1994) Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 32: 2677-2681.
12. Heritier C, Dubouix A, Poirel L, Marty N, Nordmann P (2005) A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother 55: 115-118.
13. Kempf M, Rolain JM, Azza S, Diene S, Joly-Guillou ML, et al. (2013) Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation. APMIS 121: 64-71.
14. Bonnin RA, Cuzon G, Poirel L, Nordmann P (2013) Multidrug-resistant Acinetobacter baumannii clone, France. Emerg Infect Dis 19: 822-823.
15. Decousser JW, Jansen C, Nordmann P, Emirian A, Bonnin RA, et al. (2013) Outbreak of NDM-1- producing Acinetobacter baumannii in France, January to May 2013. Euro Surveill 18.
16. Group TRTRWG (2009) "RAISIN" - a national programme for early warning, investigation and surveillance of healthcare-associated infection in France. Eurosurveillance 14: 1-8.
17. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, et al. (2006) Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44: 2974-2976.
18. National-Committee-for-Clinical-Laboratory-Standards (2010) Performance standards for antimicrobiaol susceptibility testing: twentieth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
19. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, et al. (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27: 351-353.
20. Higgins PG, Lehmann M, Seifert H (2010) Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 35: 305.
21. Bonnin RA, Nordmann P, Poirel L (2013) Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther 11: 571-583.
22. Di Popolo A, Giannouli M, Triassi M, Brisse S, Zarrilli R (2011) Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin Microbiol Infect 17: 197-201.
23. Alsultan AA, Evans BA, Elsayed EA, Al-Thawadi SI, Al-Taher AY, et al. (2013) High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia. J Med Microbiol 62: 885-888.
24. Koh TH, Tan TT, Khoo CT, Ng SY, Tan TY, et al. (2012) Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore. Epidemiol Infect 140: 535-538.
25. Zarrilli R, Pournaras S, Giannouli M, Tsakris A (2013) Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41: 11-19.
26. Karah N, Sundsfjord A, Towner K, Samuelsen O (2012) Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 15: 237-247.
27. Naas T, Coignard B, Carbonne A, Blanckaert K, Bajolet O, et al. (2006) VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 12: 1214-1222.
28. Anonymous (2013) Réseau d'alerte, d'investigation et de surveillance des infections nosocomiales (Raisin). Enquête nationale de prévalence des infections nosocomiales et des traitements anti-infectieux en établissements de santé, France, mai-juin 2012. Résultats. Saint-Maurice: InVS. 181 p.
29. Bourdon N, Fines-Guyon M, Thiolet JM, Maugat S, Coignard B, et al. (2011) Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08. J Antimicrob Chemother 66: 713-721.
30. Coignard B, Barbut F, Blanckaert K, Thiolet JM, Poujol I, et al. (2006) Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. Euro Surveill 11: E060914 060911.
31. European Centre for Disease Prevention and Control. European Antimicrobial Resistance Surveillance Network (EARS-Net). Available: http://www.ecdc.europa.eu/en/activities/surveillance/
32. Vaux S, Nguyen E, Alleaume S, Blanckaert K, Galas M, et al. (2011) Signalement des infections nosocomiales à Acinetobacter baumannii résistant à l9imipénème, France, août 2001-mai 2011. Bulletin Epidémiologique Hebdomadaire 31-32: 355-360.
33. Nemec A, Krizova L, Maixnerova M, Diancourt L, van der Reijden TJ, et al. (2008) Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 62: 484-489.
34. Endo S, Yano H, Hirakata Y, Arai K, Kanamori H, et al. (2012) Molecular epidemiology of carbapenem-non- susceptible Acinetobacter baumannii in Japan. J Antimicrob Chemother 67: 1623-1626.
35. D'Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, et al. (2011) Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother 66: 54-61.
36. Liakopoulos A, Miriagou V, Katsifas EA, Karagouni AD, Daikos GL, et al. (2012) Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill 17.
37. Minandri F, D'Arezzo S, Antunes LC, Pourcel C, Principe L, et al. (2012) Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol 50: 590-597.
38. Schleicher X, Higgins PG, Wisplinghoff H, Korber-Irrgang B, Kresken M, et al. (2013) Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009). Clin Microbiol Infect 19: 737-742.
39. Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, et al. (2011) Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 49: 3849-3854.